Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Alkermes to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cara Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
U.S. investors prepare for drawn-out House impeachment proceedings
-
Emergent BioSolutions to Participate in Cantor Fitzgerald Global Healthcare Conference
-
Emergent BioSolutions to Participate in Cantor Fitzgerald Global Healthcare Conference
-
PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Mustang Bio to Participate in October 2019 Investor Conferences
-
Fortress Biotech to Present at October 2019 Investor Conferences
-
Mustang Bio to Participate in October 2019 Investor Conferences
-
Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Fortress Biotech to Present at October 2019 Investor Conferences
-
XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
DURECT to Present at the 2019 Cantor Fitzgerald Global Health Care Conference
-
Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference
-
Curis to Present at Cantor Fitzgerald Global Healthcare Conference
-
Arbutus to Participate in Upcoming Investor Conferences
-
Arbutus to Participate in Upcoming Investor Conferences
-
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
-
AVEO Oncology to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Codexis to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Transfers Coverage on electroCore Inc. (ECOR) at Neutral
-
U.S. stocks, bond yields slip on report against Trump
-
Dicerna™ to Present at Two Upcoming Investor Conferences
-
TherapeuticsMD (TXMD) Slides Show Annovera Soft Launch Expected Next Week - Cantor Fitzgerald
-
OrthoPediatrics Corp. to Participate at the Cantor Fitzgerald Global Healthcare Conference
-
Neos Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
-
AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
resTORbio to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
resTORbio to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
Moderna to Present at Upcoming Investor Conferences
-
Aerie Pharmaceuticals to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
HTG Molecular Diagnostics Announces Completion of $22.5 Million Aggregate Financing, Consisting of $19.0 Million Public Offering of Common Stock, Including the Exercise in Full of the Underwriter’s
-
Monroe Capital Sponsors Second SPAC - Thunder Bridge Acquisition II, Ltd.
-
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
-
RTI Surgical® to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York City
-
Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
-
RTI Surgical® to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York City
-
Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Spring Bank to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York, NY
-
Kadmon to Participate in Upcoming Investor Conferences
-
PolarityTE (PTE) Management Meeting Bodes Well for Upcoming Conference Presentation - Cantor Fitzgerald
-
Pagaya Surpasses $500MM in Consumer ABS Issuance
-
Acadia Pharmaceuticals (ACAD) PT Raised to $56 at Cantor Fitzgerald
-
ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
HTG Molecular Diagnostics (HTGM) Prices $20M Financing, Consisting of $16.6M Public Offering of Common Stock, $3.5M Concurrent Private Placement

